NO973950L - Peroral sammensetning for kontrollert frigjöring i nedre gastrointestinaltrakt - Google Patents

Peroral sammensetning for kontrollert frigjöring i nedre gastrointestinaltrakt

Info

Publication number
NO973950L
NO973950L NO973950A NO973950A NO973950L NO 973950 L NO973950 L NO 973950L NO 973950 A NO973950 A NO 973950A NO 973950 A NO973950 A NO 973950A NO 973950 L NO973950 L NO 973950L
Authority
NO
Norway
Prior art keywords
composition
drug
pct
gastrointestinal tract
controlling agent
Prior art date
Application number
NO973950A
Other languages
English (en)
Other versions
NO312705B1 (no
NO973950D0 (no
Inventor
Martti Marvola
Esko Marttila
Reija Yrjoelae
Esa Lahdenpaeae
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO973950L publication Critical patent/NO973950L/no
Publication of NO973950D0 publication Critical patent/NO973950D0/no
Publication of NO312705B1 publication Critical patent/NO312705B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19973950A 1995-03-21 1997-08-27 Peroral sammensetning for kontrollert frigjöring i nedre gastrointestinaltrakt, samt fremgangsmåter til fremstilling derav NO312705B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio
PCT/FI1996/000164 WO1996029058A1 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract

Publications (3)

Publication Number Publication Date
NO973950L true NO973950L (no) 1997-08-27
NO973950D0 NO973950D0 (no) 1997-08-27
NO312705B1 NO312705B1 (no) 2002-06-24

Family

ID=8543092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973950A NO312705B1 (no) 1995-03-21 1997-08-27 Peroral sammensetning for kontrollert frigjöring i nedre gastrointestinaltrakt, samt fremgangsmåter til fremstilling derav

Country Status (16)

Country Link
US (1) US5962024A (no)
EP (1) EP0817615B1 (no)
JP (1) JPH11502217A (no)
AT (1) ATE221771T1 (no)
AU (1) AU694849B2 (no)
CA (1) CA2213747A1 (no)
DE (1) DE69622850T2 (no)
DK (1) DK0817615T3 (no)
ES (1) ES2181874T3 (no)
FI (1) FI98343C (no)
IL (1) IL117582A (no)
NO (1) NO312705B1 (no)
NZ (1) NZ303683A (no)
PT (1) PT817615E (no)
WO (1) WO1996029058A1 (no)
ZA (1) ZA962271B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
AU2003268330A1 (en) * 2002-08-29 2004-03-19 Activbiotics, Inc. Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US20050025829A1 (en) * 2003-07-29 2005-02-03 Kim Cherng-Ju Controlled drug release tablets
CA2536401C (en) 2003-11-04 2011-08-30 Shire Laboratories Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
CA2537103C (en) 2003-11-04 2010-01-19 Shire Laboratories, Inc. Once daily dosage forms of trospium
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US10071060B2 (en) * 2005-07-08 2018-09-11 Bioventures, Llc Asymmetrically coated table
US20080139526A1 (en) * 2006-12-06 2008-06-12 Donald Treacy Modified release dosage forms of amoxicillin
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US7713549B2 (en) * 2006-06-30 2010-05-11 Board Of Trustees Of The University Of Arkansas Extended release perforated tablet
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
MX2011003595A (es) 2008-10-03 2011-07-28 Falk Pharma Gmbh Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada.
KR101753411B1 (ko) * 2008-11-25 2017-07-03 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정 및 그의 제조 방법
EP3461477B1 (en) 2012-03-29 2021-06-30 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
MX2020004107A (es) * 2017-10-25 2020-07-24 Chiesi Farm Spa Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas.
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
JPH0334928A (ja) * 1989-06-29 1991-02-14 Teikoku Seiyaku Kk 潰瘍性大腸炎およびクローン病治療用経口投与製剤
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning

Also Published As

Publication number Publication date
IL117582A (en) 2000-02-29
ATE221771T1 (de) 2002-08-15
ES2181874T3 (es) 2003-03-01
FI951316A0 (fi) 1995-03-21
FI98343B (fi) 1997-02-28
AU694849B2 (en) 1998-07-30
JPH11502217A (ja) 1999-02-23
NO312705B1 (no) 2002-06-24
IL117582A0 (en) 1996-07-23
PT817615E (pt) 2002-12-31
DK0817615T3 (da) 2002-11-25
NO973950D0 (no) 1997-08-27
AU5006196A (en) 1996-10-08
DE69622850D1 (de) 2002-09-12
ZA962271B (en) 1996-09-30
WO1996029058A1 (en) 1996-09-26
FI951316A (fi) 1996-09-22
EP0817615A2 (en) 1998-01-14
EP0817615B1 (en) 2002-08-07
DE69622850T2 (de) 2003-04-24
CA2213747A1 (en) 1996-09-26
NZ303683A (en) 1998-07-28
US5962024A (en) 1999-10-05
FI98343C (fi) 1997-06-10

Similar Documents

Publication Publication Date Title
NO973950D0 (no) Peroral sammensetning for kontrollert frigjöring i nedre gastrointestinaltrakt
ATE251899T1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
DE69719774D1 (de) Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon
ATE291901T1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
BR9806174A (pt) Péletes tendo um núcleo revestido com um antifúngico e um polìmero
NZ260365A (en) Controlled release drug delivery device; solid core, delay coating, semi-permeable membrane, outer enteric coating
CA2268868A1 (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
ATE340574T1 (de) Neue dosisformen von substituierten benzimidazolen und verfahren zur deren verwendung
DE69636724D1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
MX9605646A (es) Preparacion de nifedipino de liberacion prolongada.
HU9301577D0 (en) Method for manufacturing peroral medical preparative
NO975218L (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
DE69630215D1 (de) Diltiazem-formulierung mit gesteuerter freigabe
NZ511448A (en) A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo
WO2002024174A3 (en) Sustained release composition containing clarithromycin
ATE235232T1 (de) Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
WO1996029058B1 (en) Peroral composition for controlled release in the lower gastrointestinal tract
CA2271569A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2271560A1 (en) Pharmaceutical dosage form for colonic delivery
BR9612800A (pt) Forma de dosagem farmacêutica para distribuição colÈnica.
NO992350L (no) Farmas°ytisk doseringsform med multiple enteriske polymerbelegg for avlevering i tykktarmen
NO992349L (no) Farmas°ytisk doseform for avlevering i tykktarmen
TH22631A (th) ลูกกลมแบบใหม่สำหรับควบคุมการปล่อยสารและการเตรียมยาที่ประกอบด้วยลูกกลมชนิดเดียวกัน

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees